Japan Tissue Engineering Balance Sheet

Financials in millions JPY. Fiscal year is April - March.

Millions JPY. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Cash & Equivalents	3,250	3,885	4,266	4,134	4,933
Cash & Short-Term Investments	3,250	3,885	4,266	4,134	4,933
Cash Growth	-16.35%	-8.93%	3.19%	-16.20%	-6.48%
Receivables	546	594	608	576	496
Inventory	235	181	228	237	187
Prepaid Expenses	28	30	32	21	18
Other Current Assets	123	134	205	243	311
Total Current Assets	4,182	4,824	5,339	5,211	5,945
Property, Plant & Equipment	1,336	1,420	1,510	1,567	1,613
Long-Term Investments	114	171	36	10	2
Other Intangible Assets	50	96	102	93	36
Other Long-Term Assets	-	1	1	2	2
Total Assets	5,682	6,512	6,988	6,883	7,598
Accounts Payable	107	109	84	136	117
Accrued Expenses	143	151	180	151	151
Current Income Taxes Payable	190	208	245	337	301
Other Current Liabilities	120	169	364	287	327
Total Current Liabilities	560	637	873	911	896
Pension & Post-Retirement Benefits	32	50	34	34	34
Other Long-Term Liabilities	-	-	1	1	2
Total Liabilities	592	687	908	946	932
Common Stock	3,997	4,958	4,958	4,958	4,958
Additional Paid-In Capital	1,827	2,788	2,788	2,788	2,788
Retained Earnings	-734	-1,922	-1,666	-1,810	-1,080
Comprehensive Income & Other	-	1	-	1	-
Shareholders' Equity	5,090	5,825	6,080	5,937	6,666
Total Liabilities & Equity	5,682	6,512	6,988	6,883	7,598
Net Cash (Debt)	3,250	3,885	4,266	4,134	4,933
Net Cash Growth	-16.35%	-8.93%	3.19%	-16.20%	-6.48%
Net Cash Per Share	80.03	95.67	105.05	101.80	121.47
Filing Date Shares Outstanding	40.61	40.61	40.61	40.61	40.61
Total Common Shares Outstanding	40.61	40.61	40.61	40.61	40.61
Working Capital	3,622	4,187	4,466	4,300	5,049
Book Value Per Share	125.34	143.44	149.72	146.20	164.15
Tangible Book Value	5,040	5,729	5,978	5,844	6,630
Tangible Book Value Per Share	124.11	141.07	147.21	143.91	163.26
Order Backlog	-	245	401	224	184